Structure

Physi-Chem Properties

Molecular Weight:  250.16
Volume:  269.345
LogP:  2.911
LogD:  2.689
LogS:  -2.77
# Rotatable Bonds:  3
TPSA:  43.37
# H-Bond Aceptor:  3
# H-Bond Donor:  0
# Rings:  2
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.571
Synthetic Accessibility Score:  4.094
Fsp3:  0.733
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.513
MDCK Permeability:  3.277653377153911e-05
Pgp-inhibitor:  0.316
Pgp-substrate:  0.017
Human Intestinal Absorption (HIA):  0.013
20% Bioavailability (F20%):  0.065
30% Bioavailability (F30%):  0.624

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.64
Plasma Protein Binding (PPB):  69.28083038330078%
Volume Distribution (VD):  1.006
Pgp-substrate:  34.832664489746094%

ADMET: Metabolism

CYP1A2-inhibitor:  0.129
CYP1A2-substrate:  0.122
CYP2C19-inhibitor:  0.052
CYP2C19-substrate:  0.795
CYP2C9-inhibitor:  0.027
CYP2C9-substrate:  0.315
CYP2D6-inhibitor:  0.011
CYP2D6-substrate:  0.143
CYP3A4-inhibitor:  0.501
CYP3A4-substrate:  0.377

ADMET: Excretion

Clearance (CL):  11.141
Half-life (T1/2):  0.595

ADMET: Toxicity

hERG Blockers:  0.012
Human Hepatotoxicity (H-HT):  0.605
Drug-inuced Liver Injury (DILI):  0.752
AMES Toxicity:  0.016
Rat Oral Acute Toxicity:  0.037
Maximum Recommended Daily Dose:  0.818
Skin Sensitization:  0.101
Carcinogencity:  0.913
Eye Corrosion:  0.354
Eye Irritation:  0.375
Respiratory Toxicity:  0.861

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC296522

Natural Product ID:  NPC296522
Common Name*:   KVWUOMNJFDNWQM-FRJFDASCSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  KVWUOMNJFDNWQM-FRJFDASCSA-N
Standard InCHI:  InChI=1S/C15H22O3/c1-9-8-14-13(11(3)15(17)18-14)7-6-12(9)5-4-10(2)16/h6,9,11,13-14H,4-5,7-8H2,1-3H3/t9-,11+,13+,14-/m0/s1
SMILES:  CC(=O)CCC1=CC[C@H]2[C@H](C[C@@H]1C)OC(=O)[C@@H]2C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3594243
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0001543] Sesquiterpene lactones
            • [CHEMONTID:0000502] Xanthanolides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO17612 Xanthium sibiricum Species Asteraceae Eukaryota Fruits n.a. n.a. PMID[26110443]
NPO17612 Xanthium sibiricum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO17612 Xanthium sibiricum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO17612 Xanthium sibiricum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO17612 Xanthium sibiricum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO17612 Xanthium sibiricum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT189 Cell Line Vero Chlorocebus aethiops TC50 = 77.6 uM PMID[508827]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 10000.0 nM PMID[508827]
NPT3119 Organism Human coxsackievirus B3 Human coxsackievirus B3 IC50 = 6400.0 nM PMID[508827]
NPT2 Others Unspecified Selectivity Index = 12.1 n.a. PMID[508827]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 35000.0 nM PMID[508827]
NPT32 Organism Mus musculus Mus musculus Inhibition < 20.0 % PMID[508827]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC296522 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC144511
0.9545 High Similarity NPC472955
0.9143 High Similarity NPC266159
0.9143 High Similarity NPC472967
0.913 High Similarity NPC472966
0.9014 High Similarity NPC195785
0.9014 High Similarity NPC15975
0.9 High Similarity NPC226669
0.9 High Similarity NPC193351
0.9 High Similarity NPC138408
0.8986 High Similarity NPC472956
0.8873 High Similarity NPC472959
0.8824 High Similarity NPC199557
0.875 High Similarity NPC65603
0.8592 High Similarity NPC469643
0.8592 High Similarity NPC469641
0.8571 High Similarity NPC129665
0.8533 High Similarity NPC39411
0.8533 High Similarity NPC470241
0.8533 High Similarity NPC255580
0.8514 High Similarity NPC182550
0.8514 High Similarity NPC264227
0.8514 High Similarity NPC63649
0.8514 High Similarity NPC472965
0.8493 Intermediate Similarity NPC476794
0.8493 Intermediate Similarity NPC470240
0.8472 Intermediate Similarity NPC155587
0.8472 Intermediate Similarity NPC324762
0.84 Intermediate Similarity NPC302426
0.8289 Intermediate Similarity NPC281949
0.8289 Intermediate Similarity NPC301477
0.8289 Intermediate Similarity NPC25684
0.8286 Intermediate Similarity NPC5714
0.8267 Intermediate Similarity NPC470239
0.8267 Intermediate Similarity NPC470244
0.8205 Intermediate Similarity NPC165287
0.8182 Intermediate Similarity NPC89555
0.8158 Intermediate Similarity NPC74673
0.8158 Intermediate Similarity NPC276356
0.8158 Intermediate Similarity NPC69271
0.8133 Intermediate Similarity NPC128276
0.8133 Intermediate Similarity NPC35574
0.8133 Intermediate Similarity NPC472960
0.8133 Intermediate Similarity NPC299235
0.8108 Intermediate Similarity NPC474527
0.8108 Intermediate Similarity NPC471726
0.8108 Intermediate Similarity NPC235906
0.8101 Intermediate Similarity NPC78089
0.8077 Intermediate Similarity NPC39588
0.8077 Intermediate Similarity NPC318468
0.8056 Intermediate Similarity NPC163003
0.8052 Intermediate Similarity NPC475665
0.8052 Intermediate Similarity NPC35089
0.8052 Intermediate Similarity NPC10276
0.8026 Intermediate Similarity NPC89128
0.8 Intermediate Similarity NPC474760
0.8 Intermediate Similarity NPC41780
0.8 Intermediate Similarity NPC57744
0.8 Intermediate Similarity NPC107787
0.8 Intermediate Similarity NPC187568
0.7975 Intermediate Similarity NPC472957
0.7975 Intermediate Similarity NPC472958
0.7975 Intermediate Similarity NPC115786
0.7945 Intermediate Similarity NPC470237
0.7945 Intermediate Similarity NPC58956
0.7945 Intermediate Similarity NPC269206
0.7945 Intermediate Similarity NPC295633
0.7917 Intermediate Similarity NPC475310
0.7901 Intermediate Similarity NPC237540
0.7875 Intermediate Similarity NPC33570
0.7875 Intermediate Similarity NPC161957
0.7875 Intermediate Similarity NPC165162
0.7875 Intermediate Similarity NPC21471
0.7857 Intermediate Similarity NPC304665
0.7857 Intermediate Similarity NPC154728
0.7857 Intermediate Similarity NPC126899
0.7848 Intermediate Similarity NPC215294
0.7838 Intermediate Similarity NPC476355
0.7838 Intermediate Similarity NPC140287
0.7821 Intermediate Similarity NPC471325
0.7821 Intermediate Similarity NPC207188
0.7792 Intermediate Similarity NPC178277
0.7792 Intermediate Similarity NPC617
0.7792 Intermediate Similarity NPC469690
0.7778 Intermediate Similarity NPC477448
0.7778 Intermediate Similarity NPC477449
0.775 Intermediate Similarity NPC156485
0.7733 Intermediate Similarity NPC471491
0.7733 Intermediate Similarity NPC475861
0.7722 Intermediate Similarity NPC173609
0.7703 Intermediate Similarity NPC107783
0.7703 Intermediate Similarity NPC92909
0.7692 Intermediate Similarity NPC223904
0.7662 Intermediate Similarity NPC11796
0.7662 Intermediate Similarity NPC218817
0.7654 Intermediate Similarity NPC235792
0.7632 Intermediate Similarity NPC123360
0.7632 Intermediate Similarity NPC226242
0.7632 Intermediate Similarity NPC41017
0.7625 Intermediate Similarity NPC470948
0.76 Intermediate Similarity NPC259599
0.76 Intermediate Similarity NPC167049
0.76 Intermediate Similarity NPC294434
0.76 Intermediate Similarity NPC117746
0.76 Intermediate Similarity NPC320537
0.76 Intermediate Similarity NPC143979
0.76 Intermediate Similarity NPC15499
0.76 Intermediate Similarity NPC469691
0.7595 Intermediate Similarity NPC141810
0.7595 Intermediate Similarity NPC52861
0.7595 Intermediate Similarity NPC42470
0.759 Intermediate Similarity NPC190718
0.7564 Intermediate Similarity NPC270126
0.7564 Intermediate Similarity NPC469620
0.7561 Intermediate Similarity NPC70422
0.7561 Intermediate Similarity NPC104961
0.7561 Intermediate Similarity NPC67493
0.7561 Intermediate Similarity NPC70555
0.7532 Intermediate Similarity NPC122264
0.7532 Intermediate Similarity NPC97516
0.7532 Intermediate Similarity NPC476028
0.7532 Intermediate Similarity NPC208223
0.7532 Intermediate Similarity NPC7563
0.7532 Intermediate Similarity NPC171204
0.7532 Intermediate Similarity NPC116177
0.7532 Intermediate Similarity NPC320630
0.7532 Intermediate Similarity NPC141789
0.7531 Intermediate Similarity NPC139566
0.7531 Intermediate Similarity NPC96259
0.7531 Intermediate Similarity NPC100391
0.7531 Intermediate Similarity NPC141193
0.7531 Intermediate Similarity NPC295799
0.75 Intermediate Similarity NPC170167
0.75 Intermediate Similarity NPC216407
0.75 Intermediate Similarity NPC268298
0.75 Intermediate Similarity NPC244166
0.75 Intermediate Similarity NPC469868
0.75 Intermediate Similarity NPC469678
0.75 Intermediate Similarity NPC475771
0.75 Intermediate Similarity NPC178676
0.75 Intermediate Similarity NPC469669
0.7468 Intermediate Similarity NPC293418
0.7468 Intermediate Similarity NPC304795
0.7468 Intermediate Similarity NPC51507
0.7468 Intermediate Similarity NPC73052
0.7468 Intermediate Similarity NPC290508
0.7468 Intermediate Similarity NPC6823
0.7468 Intermediate Similarity NPC200446
0.7468 Intermediate Similarity NPC195424
0.7467 Intermediate Similarity NPC135703
0.7465 Intermediate Similarity NPC474329
0.7465 Intermediate Similarity NPC474304
0.7439 Intermediate Similarity NPC52628
0.7439 Intermediate Similarity NPC470223
0.7439 Intermediate Similarity NPC110405
0.7439 Intermediate Similarity NPC177932
0.7439 Intermediate Similarity NPC125290
0.7436 Intermediate Similarity NPC108816
0.7436 Intermediate Similarity NPC471220
0.7436 Intermediate Similarity NPC471465
0.7436 Intermediate Similarity NPC196653
0.7436 Intermediate Similarity NPC267231
0.7436 Intermediate Similarity NPC474341
0.7436 Intermediate Similarity NPC93763
0.7436 Intermediate Similarity NPC469495
0.7412 Intermediate Similarity NPC62815
0.7412 Intermediate Similarity NPC129419
0.7412 Intermediate Similarity NPC37607
0.7412 Intermediate Similarity NPC301969
0.7412 Intermediate Similarity NPC253144
0.7407 Intermediate Similarity NPC474703
0.7407 Intermediate Similarity NPC108045
0.7407 Intermediate Similarity NPC475622
0.7407 Intermediate Similarity NPC475947
0.7407 Intermediate Similarity NPC272814
0.7407 Intermediate Similarity NPC475989
0.7407 Intermediate Similarity NPC193198
0.7403 Intermediate Similarity NPC473223
0.7403 Intermediate Similarity NPC279537
0.7403 Intermediate Similarity NPC92489
0.7397 Intermediate Similarity NPC470256
0.7397 Intermediate Similarity NPC476614
0.7381 Intermediate Similarity NPC215831
0.7381 Intermediate Similarity NPC91248
0.7381 Intermediate Similarity NPC474845
0.7381 Intermediate Similarity NPC224652
0.7381 Intermediate Similarity NPC28227
0.7368 Intermediate Similarity NPC474551
0.7349 Intermediate Similarity NPC279859
0.7349 Intermediate Similarity NPC38576
0.7349 Intermediate Similarity NPC6979
0.7344 Intermediate Similarity NPC244452
0.7342 Intermediate Similarity NPC209995
0.7342 Intermediate Similarity NPC98557
0.7342 Intermediate Similarity NPC167881
0.7333 Intermediate Similarity NPC29328
0.7333 Intermediate Similarity NPC288667
0.7333 Intermediate Similarity NPC40327
0.7326 Intermediate Similarity NPC123177
0.7326 Intermediate Similarity NPC150978

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC296522 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7439 Intermediate Similarity NPD1694 Approved
0.7375 Intermediate Similarity NPD5369 Approved
0.7294 Intermediate Similarity NPD1695 Approved
0.7284 Intermediate Similarity NPD6435 Approved
0.7229 Intermediate Similarity NPD1733 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7521 Approved
0.7143 Intermediate Similarity NPD7334 Approved
0.7143 Intermediate Similarity NPD7146 Approved
0.7143 Intermediate Similarity NPD6409 Approved
0.7143 Intermediate Similarity NPD6684 Approved
0.7143 Intermediate Similarity NPD5330 Approved
0.7079 Intermediate Similarity NPD1698 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD4270 Approved
0.7073 Intermediate Similarity NPD4269 Approved
0.7037 Intermediate Similarity NPD5368 Approved
0.7 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.6988 Remote Similarity NPD5362 Discontinued
0.6988 Remote Similarity NPD7154 Phase 3
0.6977 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6977 Remote Similarity NPD6903 Approved
0.6941 Remote Similarity NPD5786 Approved
0.6867 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6854 Remote Similarity NPD6399 Phase 3
0.6835 Remote Similarity NPD8039 Approved
0.6829 Remote Similarity NPD4252 Approved
0.6824 Remote Similarity NPD5363 Approved
0.6782 Remote Similarity NPD6672 Approved
0.6782 Remote Similarity NPD5737 Approved
0.6757 Remote Similarity NPD2685 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5209 Approved
0.6629 Remote Similarity NPD5207 Approved
0.6629 Remote Similarity NPD5785 Approved
0.6628 Remote Similarity NPD6082 Clinical (unspecified phase)
0.6627 Remote Similarity NPD5790 Clinical (unspecified phase)
0.6593 Remote Similarity NPD7900 Approved
0.6593 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6567 Remote Similarity NPD29 Approved
0.6567 Remote Similarity NPD28 Approved
0.6552 Remote Similarity NPD6098 Approved
0.6522 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6517 Remote Similarity NPD6101 Approved
0.6517 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6471 Remote Similarity NPD3667 Approved
0.6452 Remote Similarity NPD5349 Clinical (unspecified phase)
0.6447 Remote Similarity NPD7331 Phase 2
0.6429 Remote Similarity NPD4822 Approved
0.6429 Remote Similarity NPD4820 Approved
0.6429 Remote Similarity NPD4821 Approved
0.6429 Remote Similarity NPD4819 Approved
0.6413 Remote Similarity NPD6001 Approved
0.6413 Remote Similarity NPD7748 Approved
0.6413 Remote Similarity NPD5282 Discontinued
0.6404 Remote Similarity NPD5208 Approved
0.64 Remote Similarity NPD3197 Phase 1
0.6395 Remote Similarity NPD5332 Approved
0.6395 Remote Similarity NPD5331 Approved
0.6386 Remote Similarity NPD4271 Approved
0.6386 Remote Similarity NPD4268 Approved
0.6383 Remote Similarity NPD7902 Approved
0.6377 Remote Similarity NPD3172 Approved
0.6374 Remote Similarity NPD6411 Approved
0.6364 Remote Similarity NPD3618 Phase 1
0.6364 Remote Similarity NPD4249 Approved
0.6364 Remote Similarity NPD6422 Discontinued
0.6353 Remote Similarity NPD4790 Discontinued
0.6344 Remote Similarity NPD5695 Phase 3
0.6333 Remote Similarity NPD6904 Approved
0.6333 Remote Similarity NPD6673 Approved
0.6333 Remote Similarity NPD6080 Approved
0.6322 Remote Similarity NPD3665 Phase 1
0.6322 Remote Similarity NPD3668 Phase 3
0.6322 Remote Similarity NPD3133 Approved
0.6322 Remote Similarity NPD3666 Approved
0.6322 Remote Similarity NPD4786 Approved
0.6316 Remote Similarity NPD5696 Approved
0.6304 Remote Similarity NPD5778 Approved
0.6304 Remote Similarity NPD5779 Approved
0.6292 Remote Similarity NPD4251 Approved
0.6292 Remote Similarity NPD4250 Approved
0.6292 Remote Similarity NPD3573 Approved
0.6286 Remote Similarity NPD4266 Approved
0.6286 Remote Similarity NPD3195 Phase 2
0.6286 Remote Similarity NPD3194 Approved
0.6286 Remote Similarity NPD3196 Approved
0.6264 Remote Similarity NPD46 Approved
0.6264 Remote Similarity NPD5692 Phase 3
0.6264 Remote Similarity NPD6698 Approved
0.6263 Remote Similarity NPD6008 Approved
0.6211 Remote Similarity NPD6083 Phase 2
0.6211 Remote Similarity NPD6084 Phase 2
0.62 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6196 Remote Similarity NPD5694 Approved
0.6196 Remote Similarity NPD6050 Approved
0.6196 Remote Similarity NPD7983 Approved
0.6196 Remote Similarity NPD5693 Phase 1
0.6196 Remote Similarity NPD7515 Phase 2
0.618 Remote Similarity NPD5279 Phase 3
0.6176 Remote Similarity NPD6371 Approved
0.6163 Remote Similarity NPD857 Phase 3
0.6154 Remote Similarity NPD5370 Suspended
0.6119 Remote Similarity NPD5343 Approved
0.6104 Remote Similarity NPD7341 Phase 2
0.6087 Remote Similarity NPD3673 Approved
0.6087 Remote Similarity NPD3672 Approved
0.6081 Remote Similarity NPD3198 Approved
0.6061 Remote Similarity NPD3174 Discontinued
0.6026 Remote Similarity NPD6108 Clinical (unspecified phase)
0.6022 Remote Similarity NPD8035 Phase 2
0.6022 Remote Similarity NPD5281 Approved
0.6022 Remote Similarity NPD5284 Approved
0.6022 Remote Similarity NPD8034 Phase 2
0.6022 Remote Similarity NPD4810 Clinical (unspecified phase)
0.6 Remote Similarity NPD4137 Phase 3
0.6 Remote Similarity NPD1145 Discontinued
0.5979 Remote Similarity NPD4225 Approved
0.5978 Remote Similarity NPD5328 Approved
0.5957 Remote Similarity NPD5781 Clinical (unspecified phase)
0.5941 Remote Similarity NPD5739 Approved
0.5941 Remote Similarity NPD6675 Approved
0.5941 Remote Similarity NPD7128 Approved
0.5941 Remote Similarity NPD6402 Approved
0.5938 Remote Similarity NPD7839 Suspended
0.5926 Remote Similarity NPD4747 Approved
0.5926 Remote Similarity NPD4691 Approved
0.5922 Remote Similarity NPD6372 Approved
0.5922 Remote Similarity NPD6373 Approved
0.5909 Remote Similarity NPD4221 Approved
0.5909 Remote Similarity NPD2699 Approved
0.5909 Remote Similarity NPD4223 Phase 3
0.59 Remote Similarity NPD6052 Approved
0.5897 Remote Similarity NPD9496 Clinical (unspecified phase)
0.5889 Remote Similarity NPD7520 Clinical (unspecified phase)
0.5882 Remote Similarity NPD4756 Discovery
0.5882 Remote Similarity NPD5701 Approved
0.5882 Remote Similarity NPD622 Approved
0.5882 Remote Similarity NPD5697 Approved
0.5875 Remote Similarity NPD3621 Clinical (unspecified phase)
0.5875 Remote Similarity NPD229 Approved
0.5862 Remote Similarity NPD4695 Discontinued
0.5857 Remote Similarity NPD6927 Phase 3
0.5854 Remote Similarity NPD5276 Approved
0.5854 Remote Similarity NPD5777 Approved
0.5851 Remote Similarity NPD6079 Approved
0.5851 Remote Similarity NPD7637 Suspended
0.5833 Remote Similarity NPD5654 Approved
0.5833 Remote Similarity NPD615 Clinical (unspecified phase)
0.5833 Remote Similarity NPD9298 Approved
0.5825 Remote Similarity NPD6011 Approved
0.5825 Remote Similarity NPD6899 Approved
0.5825 Remote Similarity NPD6881 Approved
0.5825 Remote Similarity NPD7320 Approved
0.5821 Remote Similarity NPD634 Phase 3
0.5816 Remote Similarity NPD7638 Approved
0.5814 Remote Similarity NPD3732 Approved
0.581 Remote Similarity NPD6649 Approved
0.581 Remote Similarity NPD6650 Approved
0.5806 Remote Similarity NPD6051 Approved
0.5806 Remote Similarity NPD4753 Phase 2
0.5797 Remote Similarity NPD3173 Approved
0.5789 Remote Similarity NPD4246 Clinical (unspecified phase)
0.5789 Remote Similarity NPD4202 Approved
0.5778 Remote Similarity NPD4197 Approved
0.5773 Remote Similarity NPD4697 Phase 3
0.5769 Remote Similarity NPD5325 Clinical (unspecified phase)
0.5769 Remote Similarity NPD6014 Approved
0.5769 Remote Similarity NPD6012 Approved
0.5769 Remote Similarity NPD6013 Approved
0.5758 Remote Similarity NPD7640 Approved
0.5758 Remote Similarity NPD7639 Approved
0.5733 Remote Similarity NPD287 Approved
0.5714 Remote Similarity NPD7290 Approved
0.5714 Remote Similarity NPD5959 Approved
0.5714 Remote Similarity NPD5329 Approved
0.5714 Remote Similarity NPD6883 Approved
0.5714 Remote Similarity NPD5733 Approved
0.5714 Remote Similarity NPD4058 Approved
0.5714 Remote Similarity NPD4687 Approved
0.5714 Remote Similarity NPD7102 Approved
0.5714 Remote Similarity NPD368 Approved
0.5673 Remote Similarity NPD6686 Approved
0.5672 Remote Similarity NPD6097 Approved
0.5672 Remote Similarity NPD6096 Approved
0.567 Remote Similarity NPD1693 Approved
0.567 Remote Similarity NPD5210 Approved
0.567 Remote Similarity NPD4629 Approved
0.566 Remote Similarity NPD2181 Clinical (unspecified phase)
0.566 Remote Similarity NPD6401 Clinical (unspecified phase)
0.566 Remote Similarity NPD8130 Phase 1
0.566 Remote Similarity NPD6869 Approved
0.566 Remote Similarity NPD8413 Clinical (unspecified phase)
0.566 Remote Similarity NPD6617 Approved
0.566 Remote Similarity NPD6847 Approved
0.5652 Remote Similarity NPD3574 Clinical (unspecified phase)
0.5652 Remote Similarity NPD5205 Approved
0.5652 Remote Similarity NPD4693 Phase 3
0.5652 Remote Similarity NPD5690 Phase 2
0.5652 Remote Similarity NPD4694 Approved
0.5652 Remote Similarity NPD4689 Approved
0.5652 Remote Similarity NPD4688 Approved
0.5652 Remote Similarity NPD4138 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data